 Irreversible tubulointerstitial damage chronic aminonucleoside nephrosis Amelioration angiotensin enzyme inhibition Chronic nephrosis tubulointerstitial damage route frequency drug administration different groups injurious tubulointerstitial process reversible resolution heavy proteinuria normal values authors single jugular intravenous administration puromycin aminonucleoside PA Munich-Wistar rats triphasic pattern glomerular injury proteinuria focal glomerulosclerosis weeks drug administration authors later progression tubulointerstitial morphologic abnormalities acute nephrosis phase spontaneous resolution glomerular injury intermediate period phase II model treatment rats angiotensin enzyme inhibitor enalapril mg/l drinking water period magnitude proteinuria acute nephrotic phase recurrence proteinuria phase III severity interstitial fibrosis extent tubular dilatation number intratubular casts semiquantitative scoring conclusion study addition enalapril-treated rats low-molecular-weight protein excretion recurrent phase proteinuria preservation tubular functional capacity proteins vitro cytotoxicity studies glomerular visceral epithelial cell sensitive PA contrast rat tubular epithelium cellular controls exact pathogenetic mechanism responsible development tubulointerstitial damage unknown PA vitro affect rat tubular epithelium clear correlation magnitude recurrent proteinuria severity tubulointerstitial morphologic abnormalities beneficial effect enzyme inhibition untoward processes